Effect sinorphan enkephalinase inhibitor plasma atrial natriuretic factor sodium urinary excretion cirrhotic patients ascites acute effects sinorphan inhibitor enkephalinase plasma atrial natriuretic factor ANF urinary sodium excretion cirrhotic patients ascites single oral dose sinorphan mg patients placebo double blind cross-over protocol Basal plasma ANF levels large range pmol/L Sinorphan dose mg plasma enkephalinase activity min ingestion increase plasma ANF cGMP levels times basal values transient increase sodium urinary output change creatinine clearance initial period drug administration increase urinary cGMP period Plasma aldosterone concentration peak plasma ANF Mean blood pressure PRA effects mg plasma ANF cGMP aldosterone significant dose enkephalinase inhibition sodium urinary excretion cirrhotic patients ascites mechanism likely reduction ANF catabolism results ANF role control sodium homeostasis liver cirrhosis ascites 